Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Zai Lab LtdZLAB · Entity 4271 | See Remarks | June 25, 2024 | June 27, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Zai Lab Ltd
Report date June 25, 2024 · Filed June 27, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| American Depositary SharesSEC Table I · non-derivative | Direct | 62,619 |
Last balance in matching sequence
After 2024-06-26 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2024-06-25 · Exercise / conversion · Acquired 18,250 · Balance 70,050 F1: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. F2: ADSs acquired upon vesting of Restricted Share Units ("RSUs"). F3: Each RSU represents a contingent right to receive one ADS. Row 2 · 2024-06-26 · Sale · Disposed 7,431 · Balance 62,619 F1: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. F4: These ADSs were sold automatically to cover taxes upon vesting of RSUs. |
| Restricted Share UnitsSEC Table II · derivative / convertible security | Direct | 36,500 |
Reported balance
After 2024-06-25 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-06-25 · Exercise / conversion · Disposed 18,250 · Balance 36,500 F3: Each RSU represents a contingent right to receive one ADS. F5: The RSUs vest in equal annual installments over four years beginning on 06/25/2023, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting. F1: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. |
Filing footnotes · ownership attribution and instrument terms
F1: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs.
F2: ADSs acquired upon vesting of Restricted Share Units ("RSUs").
F3: Each RSU represents a contingent right to receive one ADS.
F4: These ADSs were sold automatically to cover taxes upon vesting of RSUs.
F5: The RSUs vest in equal annual installments over four years beginning on 06/25/2023, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 26, 2024 Filed Jun 27, 2024 20:09 UTC | Zai Lab Ltd ZLAB · Entity 4271 | SaleAmerican Depositary Shares | 7,431 | $17.90 | $133,022.33 |
DisclosureSEC source: 0000905148-24-001804 · form4.xml · nonDerivative · entry 2 Reinhart Harald · CIK 0001835824 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,619 F1 · security: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. F4 · shares: These ADSs were sold automatically to cover taxes upon vesting of RSUs. Read SEC document |
| June 25, 2024 Filed Jun 27, 2024 20:09 UTC | Zai Lab Ltd ZLAB · Entity 4271 | Exercise / conversionRestricted Share Units · Derivative | 18,250 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-24-001804 · form4.xml · derivative · entry 3 Reinhart Harald · CIK 0001835824 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,500 Underlying: American Depositary Shares · 18,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one ADS. F5 · derivative.exercise_date: The RSUs vest in equal annual installments over four years beginning on 06/25/2023, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting. F5 · derivative.expiration_date: The RSUs vest in equal annual installments over four years beginning on 06/25/2023, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting. F1 · derivative.underlying: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. Read SEC document |
| June 25, 2024 Filed Jun 27, 2024 20:09 UTC | Zai Lab Ltd ZLAB · Entity 4271 | Exercise / conversionAmerican Depositary Shares | 18,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000905148-24-001804 · form4.xml · nonDerivative · entry 1 Reinhart Harald · CIK 0001835824 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,050 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. F2 · shares: ADSs acquired upon vesting of Restricted Share Units ("RSUs"). F3 · price: Each RSU represents a contingent right to receive one ADS. Read SEC document |
| April 04, 2024 Filed Apr 5, 2024 21:48 UTC | Zai Lab Ltd ZLAB · Entity 4271 | SaleAmerican Depositary Shares | 2,105 | $15.67 | $32,991.67 |
DisclosureSEC source: 0000905148-24-001113 · form4.xml · nonDerivative · entry 2 Reinhart Harald · CIK 0001835824 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,800 F1 · security: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. F3 · shares: These ADSs were sold automatically to cover taxes upon vesting of RSUs. Read SEC document |
| April 03, 2024 Filed Apr 5, 2024 21:48 UTC | Zai Lab Ltd ZLAB · Entity 4271 | Exercise / conversionRestricted Share Units · Derivative | 5,270 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-24-001113 · form4.xml · derivative · entry 3 Reinhart Harald · CIK 0001835824 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,811 Underlying: American Depositary Shares · 5,270 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one ADS. F5 · derivative.exercise_date: The RSUs vest in equal annual installments over four years beginning on 04/03/2024, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting. F5 · derivative.expiration_date: The RSUs vest in equal annual installments over four years beginning on 04/03/2024, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting. F1 · derivative.underlying: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. Read SEC document |
| April 03, 2024 Filed Apr 5, 2024 21:48 UTC | Zai Lab Ltd ZLAB · Entity 4271 | Exercise / conversionAmerican Depositary Shares | 5,270 | $15.90 | $83,793.00 |
DisclosureSEC source: 0000905148-24-001113 · form4.xml · nonDerivative · entry 1 Reinhart Harald · CIK 0001835824 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,905 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. F2 · shares: ADSs acquired upon vesting of Restricted Share Units ("RSUs"). Read SEC document |
| April 02, 2024 Filed Apr 4, 2024 01:45 UTC | Zai Lab Ltd ZLAB · Entity 4271 | SaleAmerican Depositary Shares | 413 | $16.15 | $6,670.36 |
DisclosureSEC source: 0000905148-24-001094 · form4.xml · nonDerivative · entry 4 Reinhart Harald · CIK 0001835824 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,635 F1 · security: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. F3 · shares: These ADSs were sold automatically to cover taxes upon vesting of Restricted Share Units. Read SEC document |
| April 02, 2024 Filed Apr 4, 2024 01:45 UTC | Zai Lab Ltd ZLAB · Entity 4271 | SaleAmerican Depositary Shares | 1,360 | $16.15 | $21,965.36 |
DisclosureSEC source: 0000905148-24-001094 · form4.xml · nonDerivative · entry 3 Reinhart Harald · CIK 0001835824 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,048 F1 · security: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. F3 · shares: These ADSs were sold automatically to cover taxes upon vesting of Restricted Share Units. Read SEC document |
| April 01, 2024 Filed Apr 4, 2024 01:45 UTC | Zai Lab Ltd ZLAB · Entity 4271 | Exercise / conversionRestricted Share Units · Derivative | 1,010 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-24-001094 · form4.xml · derivative · entry 8 Reinhart Harald · CIK 0001835824 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,020 Underlying: American Depositary Shares · 1,010 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Each Restricted Share Unit ("RSU") represents a contingent right to receive one ADS, which represents ten Ordinary Shares of the issuer. F9 · derivative.exercise_date: The RSUs vest in equal annual installments over five years beginning on 04/01/2022, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting. F9 · derivative.expiration_date: The RSUs vest in equal annual installments over five years beginning on 04/01/2022, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting. F1 · derivative.underlying: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. Read SEC document |
| April 01, 2024 Filed Apr 4, 2024 01:45 UTC | Zai Lab Ltd ZLAB · Entity 4271 | Exercise / conversionRestricted Share Units · Derivative | 3,338 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-24-001094 · form4.xml · derivative · entry 7 Reinhart Harald · CIK 0001835824 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,016 Underlying: American Depositary Shares · 3,338 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Each Restricted Share Unit ("RSU") represents a contingent right to receive one ADS, which represents ten Ordinary Shares of the issuer. F8 · derivative.exercise_date: The RSUs vest in equal annual installments over five years beginning on 04/01/2023, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting. F8 · derivative.expiration_date: The RSUs vest in equal annual installments over five years beginning on 04/01/2023, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting. F1 · derivative.underlying: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. Read SEC document |
| April 01, 2024 Filed Apr 4, 2024 01:45 UTC | Zai Lab Ltd ZLAB · Entity 4271 | GrantRestricted Share Units · Derivative | 69,758 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-24-001094 · form4.xml · derivative · entry 6 Reinhart Harald · CIK 0001835824 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,758 Underlying: American Depositary Shares · 69,758 shares Expires not disclosed F6 · derivative.exercise_price: Each Restricted Share Unit ("RSU") represents a contingent right to receive one ADS, which represents ten Ordinary Shares of the issuer. F7 · derivative.exercise_date: The RSUs vest in equal annual installments over four years beginning on 04/01/2025, the first anniversary of the date of grant, subject to continuous service. Vested shares will be delivered to the reporting person following vesting. F7 · derivative.expiration_date: The RSUs vest in equal annual installments over four years beginning on 04/01/2025, the first anniversary of the date of grant, subject to continuous service. Vested shares will be delivered to the reporting person following vesting. F1 · derivative.underlying: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. Read SEC document |
| April 01, 2024 Filed Apr 4, 2024 01:45 UTC | Zai Lab Ltd ZLAB · Entity 4271 | GrantStock Options (Right to Buy) · Derivative | 107,321 | $0.00 Strike: $16.72 | $0.00 |
DisclosureSEC source: 0000905148-24-001094 · form4.xml · derivative · entry 5 Reinhart Harald · CIK 0001835824 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,321 Underlying: American Depositary Shares · 107,321 shares Expires 2034-04-01 F4 · security: Each Stock Option is exercisable for one ADS, which represents ten Ordinary Shares of the issuer. F5 · derivative.exercise_date: The option vests in equal annual installments over four years beginning on 04/01/2025, the first anniversary of the date of grant, subject to continuous service. F1 · derivative.underlying: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. Read SEC document |
| April 01, 2024 Filed Apr 4, 2024 01:45 UTC | Zai Lab Ltd ZLAB · Entity 4271 | Exercise / conversionAmerican Depositary Shares | 1,010 | $16.72 | $16,887.20 |
DisclosureSEC source: 0000905148-24-001094 · form4.xml · nonDerivative · entry 2 Reinhart Harald · CIK 0001835824 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,408 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. F2 · shares: ADSs acquired on vesting of Restricted Share Units. Read SEC document |
| April 01, 2024 Filed Apr 4, 2024 01:45 UTC | Zai Lab Ltd ZLAB · Entity 4271 | Exercise / conversionAmerican Depositary Shares | 3,338 | $16.72 | $55,811.36 |
DisclosureSEC source: 0000905148-24-001094 · form4.xml · nonDerivative · entry 1 Reinhart Harald · CIK 0001835824 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,398 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. F2 · shares: ADSs acquired on vesting of Restricted Share Units. Read SEC document |
| January 03, 2024 Filed Jan 4, 2024 00:25 UTC | Zai Lab Ltd ZLAB · Entity 4271 | SaleAmerican Depositary Shares | 4,803 | $26.12 | $125,463.97 |
DisclosureSEC source: 0000905148-24-000061 · form4.xml · nonDerivative · entry 2 Reinhart Harald · CIK 0001835824 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,060 F1 · security: Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. F4 · shares: These ADSs were sold automatically to cover taxes upon vesting of PSUs. Read SEC document |
| January 01, 2024 Filed Jan 4, 2024 00:25 UTC | Zai Lab Ltd ZLAB · Entity 4271 | Exercise / conversionPerformance-Based Share Units · Derivative | 17,548 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-24-000061 · form4.xml · derivative · entry 4 Reinhart Harald · CIK 0001835824 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: American Depositary Shares · 17,548 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each PSU represents a contingent right to receive one ADS, which represents ten Ordinary Shares of the issuer. F5 · derivative.exercise_date: The reporting person was granted PSUs on December 1, 2021 that vest based on the satisfaction of specified performance criteria between December 1, 2021 and December 31, 2025. On January 1, 2024, the performance-based vesting conditions were confirmed for PSUs representing 17,548 ADSs. F5 · derivative.expiration_date: The reporting person was granted PSUs on December 1, 2021 that vest based on the satisfaction of specified performance criteria between December 1, 2021 and December 31, 2025. On January 1, 2024, the performance-based vesting conditions were confirmed for PSUs representing 17,548 ADSs. F1 · derivative.underlying: Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. Read SEC document |
| January 01, 2024 Filed Jan 4, 2024 00:25 UTC | Zai Lab Ltd ZLAB · Entity 4271 | GrantPerformance-Based Share Units · Derivative | 17,548 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-24-000061 · form4.xml · derivative · entry 3 Reinhart Harald · CIK 0001835824 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,548 Underlying: American Depositary Shares · 17,548 shares Expires not disclosed F3 · derivative.exercise_price: Each PSU represents a contingent right to receive one ADS, which represents ten Ordinary Shares of the issuer. F5 · derivative.exercise_date: The reporting person was granted PSUs on December 1, 2021 that vest based on the satisfaction of specified performance criteria between December 1, 2021 and December 31, 2025. On January 1, 2024, the performance-based vesting conditions were confirmed for PSUs representing 17,548 ADSs. F5 · derivative.expiration_date: The reporting person was granted PSUs on December 1, 2021 that vest based on the satisfaction of specified performance criteria between December 1, 2021 and December 31, 2025. On January 1, 2024, the performance-based vesting conditions were confirmed for PSUs representing 17,548 ADSs. F1 · derivative.underlying: Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. Read SEC document |
| January 01, 2024 Filed Jan 4, 2024 00:25 UTC | Zai Lab Ltd ZLAB · Entity 4271 | Exercise / conversionAmerican Depositary Shares | 17,548 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000905148-24-000061 · form4.xml · nonDerivative · entry 1 Reinhart Harald · CIK 0001835824 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,863 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. F2 · shares: ADSs acquired on vesting of performance-based share units (PSUs). Each ADS represents ten Ordinary Shares of the issuer. F3 · price: Each PSU represents a contingent right to receive one ADS, which represents ten Ordinary Shares of the issuer. Read SEC document |
| June 23, 2023 Filed Jun 26, 2023 20:07 UTC | Zai Lab Ltd ZLAB · Entity 4271 | Exercise / conversionRestricted Share Units · Derivative | 18,250 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-029861 · ownership.xml · derivative · entry 3 Reinhart Harald · CIK 0001835824 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,750 Underlying: American Depositary Shares · 18,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Each Restricted Share Unit represents a contingent right to receive one ADS, which represents ten Ordinary Shares of the issuer. F5 · derivative.exercise_date: The Restricted Share Units vest in equal annual installments over four years beginning on 06/25/2023, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting. F5 · derivative.expiration_date: The Restricted Share Units vest in equal annual installments over four years beginning on 06/25/2023, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting. F1 · derivative.underlying: Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. Read SEC document |
| June 23, 2023 Filed Jun 26, 2023 20:07 UTC | Zai Lab Ltd ZLAB · Entity 4271 | Tax withholdingAmerican Depositary Shares | 7,182 | $25.30 | $181,704.60 |
DisclosureSEC source: 0000950170-23-029861 · ownership.xml · nonDerivative · entry 2 Reinhart Harald · CIK 0001835824 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,315 F1 · security: Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. F3 · kind: This transaction represents the disposition of shares to cover taxes. Read SEC document |
| June 23, 2023 Filed Jun 26, 2023 20:07 UTC | Zai Lab Ltd ZLAB · Entity 4271 | Exercise / conversionAmerican Depositary Shares | 18,250 | $25.30 | $461,725.00 |
DisclosureSEC source: 0000950170-23-029861 · ownership.xml · nonDerivative · entry 1 Reinhart Harald · CIK 0001835824 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,497 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. F2 · shares: ADSs acquired on vesting of Restricted Share Units. Each ADS represents ten Ordinary Shares of the issuer. Read SEC document |
| April 03, 2023 Filed Apr 5, 2023 20:05 UTC | Zai Lab Ltd ZLAB · Entity 4271 | GrantRestricted Share Units · Derivative | 21,081 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-010712 · doc4.xml · derivative · entry 2 Reinhart Harald · CIK 0001835824 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,081 Underlying: American Depositary Shares · 21,081 shares Expires not disclosed F4 · derivative.exercise_price: Each Restricted Share Unit represents a contingent right to receive one American Depositary Share (ADS), which represents ten Ordinary Shares of the issuer. F5 · derivative.exercise_date: The Restricted Share Units vest in equal annual installments over four years beginning on 04/03/2024, the first anniversary of the date of grant. Vested shares will be delivered to the reporting person following vesting. F5 · derivative.expiration_date: The Restricted Share Units vest in equal annual installments over four years beginning on 04/03/2024, the first anniversary of the date of grant. Vested shares will be delivered to the reporting person following vesting. F3 · derivative.underlying: Each ADS represents ten Ordinary Shares of the issuer. Read SEC document |
| April 03, 2023 Filed Apr 5, 2023 20:05 UTC | Zai Lab Ltd ZLAB · Entity 4271 | GrantStock Options (Right to Buy) · Derivative | 109,632 | $0.00 Strike: $33.95 | $0.00 |
DisclosureSEC source: 0000899243-23-010712 · doc4.xml · derivative · entry 1 Reinhart Harald · CIK 0001835824 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109,632 Underlying: American Depositary Shares · 109,632 shares Expires 2033-04-03 F1 · shares: The Stock Options are exercisable for American Depositary Shares (ADSs). The number of securities underlying each option and the exercise price therefor are represented in ADSs. Each ADS represents ten Ordinary Shares of the issuer. F2 · derivative.exercise_date: The Stock Options vest in equal annual installments over four years beginning on 04/03/2024, the first anniversary of the date of grant. F3 · derivative.underlying: Each ADS represents ten Ordinary Shares of the issuer. Read SEC document |
| March 31, 2023 Filed Apr 3, 2023 20:05 UTC | Zai Lab Ltd ZLAB · Entity 4271 | Exercise / conversionRestricted Share Units · Derivative | 1,010 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-010212 · doc4.xml · derivative · entry 6 Reinhart Harald · CIK 0001835824 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,030 Underlying: American Depositary Shares · 1,010 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each Restricted Share Unit represents a contingent right to receive one ADS, which represents ten Ordinary Shares of the issuer. F6 · derivative.exercise_date: The Restricted Share Units vest in equal annual installments over five years beginning on 04/01/2022, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting. F6 · derivative.expiration_date: The Restricted Share Units vest in equal annual installments over five years beginning on 04/01/2022, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting. F1 · derivative.underlying: Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. Read SEC document |
| March 31, 2023 Filed Apr 3, 2023 20:05 UTC | Zai Lab Ltd ZLAB · Entity 4271 | Exercise / conversionRestricted Share Units · Derivative | 3,338 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-010212 · doc4.xml · derivative · entry 5 Reinhart Harald · CIK 0001835824 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,354 Underlying: American Depositary Shares · 3,338 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each Restricted Share Unit represents a contingent right to receive one ADS, which represents ten Ordinary Shares of the issuer. F5 · derivative.exercise_date: The Restricted Share Units vest in equal annual installments over five years beginning on 04/01/2023, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting. F5 · derivative.expiration_date: The Restricted Share Units vest in equal annual installments over five years beginning on 04/01/2023, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting. F1 · derivative.underlying: Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. Read SEC document |
| March 31, 2023 Filed Apr 3, 2023 20:05 UTC | Zai Lab Ltd ZLAB · Entity 4271 | Tax withholdingAmerican Depositary Shares | 813 | $33.26 | $27,040.38 |
DisclosureSEC source: 0000899243-23-010212 · doc4.xml · nonDerivative · entry 4 Reinhart Harald · CIK 0001835824 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,247 F1 · security: Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. F3 · kind: This transaction represents the disposition of shares to cover taxes. Read SEC document |
| March 31, 2023 Filed Apr 3, 2023 20:05 UTC | Zai Lab Ltd ZLAB · Entity 4271 | Exercise / conversionAmerican Depositary Shares | 3,338 | $33.26 | $111,021.88 |
DisclosureSEC source: 0000899243-23-010212 · doc4.xml · nonDerivative · entry 3 Reinhart Harald · CIK 0001835824 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,060 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. F2 · shares: ADSs acquired on vesting of Restricted Share Units. Each ADS represents ten Ordinary Shares of the issuer. Read SEC document |
| March 31, 2023 Filed Apr 3, 2023 20:05 UTC | Zai Lab Ltd ZLAB · Entity 4271 | Tax withholdingAmerican Depositary Shares | 246 | $33.26 | $8,181.96 |
DisclosureSEC source: 0000899243-23-010212 · doc4.xml · nonDerivative · entry 2 Reinhart Harald · CIK 0001835824 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,722 F1 · security: Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. F3 · kind: This transaction represents the disposition of shares to cover taxes. Read SEC document |
| March 31, 2023 Filed Apr 3, 2023 20:05 UTC | Zai Lab Ltd ZLAB · Entity 4271 | Exercise / conversionAmerican Depositary Shares | 1,010 | $33.26 | $33,592.60 |
DisclosureSEC source: 0000899243-23-010212 · doc4.xml · nonDerivative · entry 1 Reinhart Harald · CIK 0001835824 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,968 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. F2 · shares: ADSs acquired on vesting of Restricted Share Units. Each ADS represents ten Ordinary Shares of the issuer. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 21:05 UTC | Zai Lab Ltd ZLAB · Entity 4271 | Exercise / conversionStock Options (Right to Buy) · Derivative | 11,480 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0000899243-23-007331 · doc4.xml · derivative · entry 3 Reinhart Harald · CIK 0001835824 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: American Depositary Shares · 11,480 shares Expires 2027-05-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The reported transaction was effected pursuant to a sale plan adopted by the Reporting Person, dated 08/23/2022, that expires on 06/30/2023 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F3 · derivative.exercise_date: The options vest in equal installments over four years beginning on 5/12/2018, the first anniversary of the date of grant. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 21:05 UTC | Zai Lab Ltd ZLAB · Entity 4271 | SaleAmerican Depositary Shares | 11,480 | $40.00 | $459,200.00 |
DisclosureSEC source: 0000899243-23-007331 · doc4.xml · nonDerivative · entry 2 Reinhart Harald · CIK 0001835824 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,958 F1 · security: Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. F2 · kind: The reported transaction was effected pursuant to a sale plan adopted by the Reporting Person, dated 08/23/2022, that expires on 06/30/2023 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 21:05 UTC | Zai Lab Ltd ZLAB · Entity 4271 | Exercise / conversionAmerican Depositary Shares | 11,480 | $3.00 | $34,440.00 |
DisclosureSEC source: 0000899243-23-007331 · doc4.xml · nonDerivative · entry 1 Reinhart Harald · CIK 0001835824 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,438 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. F2 · kind: The reported transaction was effected pursuant to a sale plan adopted by the Reporting Person, dated 08/23/2022, that expires on 06/30/2023 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| December 30, 2022 Filed Jan 3, 2023 21:05 UTC | Zai Lab Ltd ZLAB · Entity 4271 | Tax withholdingAmerican Depositary Shares | 5,903 | $30.70 | $181,222.10 |
DisclosureSEC source: 0000899243-23-000205 · doc4.xml · nonDerivative · entry 1 Reinhart Harald · CIK 0001835824 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,958 F1 · security: Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. F2 · kind: The shares were disposed of through a netting transaction to the issuer to cover taxes due. Read SEC document |
| November 15, 2022 Filed Nov 18, 2022 02:37 UTC | Zai Lab Ltd ZLAB · Entity 4271 | Exercise / conversionStock Options (Right to Buy) · Derivative | 1,854 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0000899243-22-036308 · doc4.xml · derivative · entry 5 Reinhart Harald · CIK 0001835824 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,480 Underlying: American Depositary Shares · 1,854 shares Expires 2027-05-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The shares were disposed of through a netting transaction to the issuer to cover taxes due. Due to an inadvertent administrative error, the disposition of such shares to cover taxes was not reported on the original Form 4. F2 · derivative.exercise_date: The shares were disposed of through a netting transaction to the issuer to cover taxes due. Due to an inadvertent administrative error, the disposition of such shares to cover taxes was not reported on the original Form 4. Read SEC document |
| November 15, 2022 Filed Nov 18, 2022 02:37 UTC | Zai Lab Ltd ZLAB · Entity 4271 | SaleAmerican Depositary Shares | 100 | $40.03 | $4,003.00 |
DisclosureSEC source: 0000899243-22-036308 · doc4.xml · nonDerivative · entry 4 Reinhart Harald · CIK 0001835824 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,861 F3 · kind: The reported transaction was effected pursuant to a sale plan adopted by the Reporting Person, dated 8/23/2022, expires 6/30/2023 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| November 15, 2022 Filed Nov 18, 2022 02:37 UTC | Zai Lab Ltd ZLAB · Entity 4271 | SaleAmerican Depositary Shares | 1,754 | $40.00 | $70,160.00 |
DisclosureSEC source: 0000899243-22-036308 · doc4.xml · nonDerivative · entry 3 Reinhart Harald · CIK 0001835824 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,961 F3 · kind: The reported transaction was effected pursuant to a sale plan adopted by the Reporting Person, dated 8/23/2022, expires 6/30/2023 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| November 15, 2022 Filed Nov 18, 2022 02:37 UTC | Zai Lab Ltd ZLAB · Entity 4271 | Exercise / conversionAmerican Depositary Shares | 1,854 | $3.00 | $5,562.00 |
DisclosureSEC source: 0000899243-22-036308 · doc4.xml · nonDerivative · entry 2 Reinhart Harald · CIK 0001835824 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,715 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The reported transaction was effected pursuant to a sale plan adopted by the Reporting Person, dated 8/23/2022, expires 6/30/2023 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| June 25, 2022 Filed Jun 28, 2022 01:42 UTC | Zai Lab Ltd ZLAB · Entity 4271 | GrantRestricted Share Units · Derivative | 73,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-024328 · doc4.xml · derivative · entry 1 Reinhart Harald · CIK 0001835824 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,000 Underlying: American Depositary Shares · 73,000 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Share Unit represents a contingent right to receive one American Depositary Share (ADS), which represents ten Ordinary Shares of the issuer. F2 · derivative.exercise_date: The Restricted Share Units vest in equal annual installments over four years beginning on 06/25/2023, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting. F2 · derivative.expiration_date: The Restricted Share Units vest in equal annual installments over four years beginning on 06/25/2023, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 20:05 UTC | Zai Lab Ltd ZLAB · Entity 4271 | Exercise / conversionRestricted Share Units · Derivative | 1,010 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-013699 · doc4.xml · derivative · entry 4 Reinhart Harald · CIK 0001835824 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,040 Underlying: American Depositary Shares · 1,010 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each Restricted Share Unit represents a contingent right to receive one ADS, which represents ten Ordinary Shares of the issuer. F7 · derivative.exercise_date: The Restricted Share Units vest in equal annual installments over five years beginning on 04/01/2022, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting. F7 · derivative.expiration_date: The Restricted Share Units vest in equal annual installments over five years beginning on 04/01/2022, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting. F1 · derivative.underlying: Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 20:05 UTC | Zai Lab Ltd ZLAB · Entity 4271 | GrantRestricted Share Units · Derivative | 16,692 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-013699 · doc4.xml · derivative · entry 3 Reinhart Harald · CIK 0001835824 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,692 Underlying: American Depositary Shares · 16,692 shares Expires not disclosed F5 · derivative.exercise_price: Each Restricted Share Unit represents a contingent right to receive one ADS, which represents ten Ordinary Shares of the issuer. F6 · derivative.exercise_date: The Restricted Share Units vest in equal annual installments over five years beginning on 04/01/2023, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting. F6 · derivative.expiration_date: The Restricted Share Units vest in equal annual installments over five years beginning on 04/01/2023, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting. F1 · derivative.underlying: Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 20:05 UTC | Zai Lab Ltd ZLAB · Entity 4271 | GrantStock Options (Right to Buy) · Derivative | 87,699 | $0.00 Strike: $45.47 | $0.00 |
DisclosureSEC source: 0000899243-22-013699 · doc4.xml · derivative · entry 2 Reinhart Harald · CIK 0001835824 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,699 Underlying: American Depositary Shares · 87,699 shares Expires 2032-04-01 F3 · shares: The Stock Options are exercisable for ADSs. The number of securities underlying each option and the exercise price therefor are represented in ADSs. Each ADS represents ten Ordinary Shares of the issuer. F4 · derivative.exercise_date: The Stock Options vest in equal annual installments over five years beginning on 04/01/2023, the first anniversary of the date of grant. F1 · derivative.underlying: Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 20:05 UTC | Zai Lab Ltd ZLAB · Entity 4271 | Exercise / conversionAmerican Depositary Shares | 1,010 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-013699 · doc4.xml · nonDerivative · entry 1 Reinhart Harald · CIK 0001835824 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,107 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. F2 · shares: ADSs acquired on vesting of Restricted Share Units. Each ADS represents ten Ordinary Shares of the issuer. Read SEC document |
| April 01, 2022 Filed Nov 18, 2022 02:37 UTC | Zai Lab Ltd ZLAB · Entity 4271 | Tax withholdingAmerican Depositary Shares | 246 | $45.47 | $11,185.62 |
DisclosureSEC source: 0000899243-22-036308 · doc4.xml · nonDerivative · entry 1 Reinhart Harald · CIK 0001835824 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,861 F1 · security: Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. F2 · security: The shares were disposed of through a netting transaction to the issuer to cover taxes due. Due to an inadvertent administrative error, the disposition of such shares to cover taxes was not reported on the original Form 4. F2 · kind: The shares were disposed of through a netting transaction to the issuer to cover taxes due. Due to an inadvertent administrative error, the disposition of such shares to cover taxes was not reported on the original Form 4. Read SEC document |
| December 29, 2021 Filed Dec 30, 2021 21:18 UTC | Zai Lab Ltd ZLAB · Entity 4271 | Tax withholdingOrdinary Shares | 5,903 | $69.23 | $408,664.69 |
DisclosureSEC source: 0001567619-21-022691 · doc1.xml · nonDerivative · entry 1 Reinhart Harald · CIK 0001835824 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,097 F1 · kind: The shares were disposed of through a netting transaction to the issuer to cover taxes due. Read SEC document |
| December 21, 2021 Filed Dec 27, 2021 14:36 UTC | Zai Lab Ltd ZLAB · Entity 4271 | GrantOrdinary Shares | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-049736 · doc4.xml · nonDerivative · entry 1 Reinhart Harald · CIK 0001835824 · See remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Read SEC document |
| September 09, 2021 Filed Sep 10, 2021 20:17 UTC | Zai Lab Ltd ZLAB · Entity 4271 | Exercise / conversionStock Options (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001567619-21-016964 · doc1.xml · derivative · entry 11 Reinhart Harald · CIK 0001835824 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,334 Underlying: Ordinary Shares · 10,000 shares Expires 2027-05-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated June 2, 2021, expires December 31, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F11 · derivative.exercise_date: The options vest in equal annual installments over four years beginning on 5/12/2018, the first anniversary of the date of grant. Read SEC document |
| September 09, 2021 Filed Sep 10, 2021 20:17 UTC | Zai Lab Ltd ZLAB · Entity 4271 | SaleOrdinary Shares | 500 | $146.61 | $73,305.00 |
DisclosureSEC source: 0001567619-21-016964 · doc1.xml · nonDerivative · entry 10 Reinhart Harald · CIK 0001835824 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated June 2, 2021, expires December 31, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F10 · price: Reflects a weighted average sale price of $146.61 per share, at prices ranging from $146.50 to $146.76 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 09, 2021 Filed Sep 10, 2021 20:17 UTC | Zai Lab Ltd ZLAB · Entity 4271 | SaleOrdinary Shares | 1,400 | $146.07 | $204,498.00 |
DisclosureSEC source: 0001567619-21-016964 · doc1.xml · nonDerivative · entry 9 Reinhart Harald · CIK 0001835824 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500 F1 · kind: The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated June 2, 2021, expires December 31, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F9 · price: Reflects a weighted average sale price of $146.07 per share, at prices ranging from $145.49 to $146.46 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 09, 2021 Filed Sep 10, 2021 20:17 UTC | Zai Lab Ltd ZLAB · Entity 4271 | SaleOrdinary Shares | 800 | $144.35 | $115,480.00 |
DisclosureSEC source: 0001567619-21-016964 · doc1.xml · nonDerivative · entry 8 Reinhart Harald · CIK 0001835824 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,900 F1 · kind: The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated June 2, 2021, expires December 31, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F8 · price: Reflects a weighted average sale price of $144.35 per share, at prices ranging from $144.09 to $144.99 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 09, 2021 Filed Sep 10, 2021 20:17 UTC | Zai Lab Ltd ZLAB · Entity 4271 | SaleOrdinary Shares | 1,600 | $143.34 | $229,344.00 |
DisclosureSEC source: 0001567619-21-016964 · doc1.xml · nonDerivative · entry 7 Reinhart Harald · CIK 0001835824 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,700 F1 · kind: The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated June 2, 2021, expires December 31, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F7 · price: Reflects a weighted average sale price of $143.34 per share, at prices ranging from $142.81 to $143.72 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.